- betamethasone valerate
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
Below is a text only representation of the Patient Information Leaflet. The original can be viewed in PDF format using the link above.
The text only version may be available from RNIB in large print, Braille or audio CD. For further information call RNIB Medicine Leaflet Line on 0800 198 5000. The product code(s) for this leaflet is: PL 00173/0149.
Betacap Scalp Application
PACKAGE LEAFLET Information for the user
Betacap™ Scalp Application
0.1% w/w cutaneous solution
betamethasone (as betamethasone valerate)
Read all of this leaflet carefully before you start using this product.
Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Betacap Scalp Application is and what it is used for
2. Before you use Betacap Scalp Application
3. How to use Betacap Scalp Application
4. Possible side effects
5. How to store Betacap Scalp Application
6. Further information
1. WHAT BETACAP SCALP APPLICATION IS AND WHAT IT IS USED FOR
2. BEFORE YOU USE BETACAP SCALP APPLICATION
Do not use Betacap Scalp Application:
Take special care when using this product:
Using other medicines
Betacap Scalp Application is not known to affect, or to be affected by, any other medicines.
Pregnancy and breast-feeding
It is unclear whether this product is safe for use during pregnancy and breast-feeding. Animal birth defects have occurred with similar medicines containing corticosteroids, so there may be a very small risk of these problems in humans. You should therefore not normally use this product if you are pregnant or breast-feeding unless your doctor has recommended you to do so.
Driving and using machinery
Using this product is not known to affect your ability to drive or use machinery.
3. HOW TO USE BETACAP SCALP APPLICATION
Use Betacap Scalp Application only on psoriasis and seborrhoeic dermatitis affecting the scalp.
Before using this bottle of Betacap Scalp Application for the first time, turn the bottle cap anti-clockwise to break the seal.
For adults and the elderly:
Repeat the following twice a day, morning and evening, until you notice an improvement in your scalp condition. On days when you shampoo your hair, apply Betacap Scalp Application after drying the hair:
When you can see that your scalp condition is getting better, you can start to apply Betacap Scalp Application less often, only once a day or even less. The frequency of application should be reduced to the minimum necessary to keep your scalp condition under control.
For children (over one year old):
If Betacap Scalp Application gets into the eyes it may cause damage. If it gets into the eyes, rinse immediately with plenty of water. If rinsing one eye, take care to avoid washing product into the other eye. If irritation persists tell your doctor or pharmacist.
Betacap Scalp Application is dangerous if swallowed.
If someone swallows this product by mistake, take the following emergency action: if they are drowsy or unconscious, give nothing by mouth. If they are conscious, encourage them to drink 1 or 2 cups of milk or water (one cup in the case of a child), but do not carry on if they are vomiting. In all cases, take them to a doctor or hospital straight away. Take this leaflet and the container of Betacap Scalp Application with you.
If you apply too much Betacap Scalp Application, use a tissue to mop up any excess and stop it spreading onto uninvolved skin areas.
If you occasionally forget to use Betacap Scalp Application, do not worry, just carry on using it when you remember.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Betacap Scalp Application can cause side effects, although not everybody gets them:
If you are in any doubt about the treatment, or experience any of the above side effects or any other side effect not mentioned in this leaflet, stop using this product and tell your doctor or pharmacist.
Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
5. HOW TO STORE BETACAP SCALP APPLICATION
6. FURTHER INFORMATION ABOUT BETACAP SCALP APPLICATION
What Betacap Scalp Application contains:
The active ingredient is betamethasone (as betamethasone valerate) 0.1% w/w.
The other ingredients are macrogol 7 glycerol cocoate, isopropyl alcohol, carbomer, sodium hydroxide and purified water.
What Betacap Scalp Application looks like and contents of the pack
The Marketing Authorisation holder is:
The Manufacturer is:
This Patient Information Leaflet was last revised in March 2015.
To listen to or request a copy of this leaflet in Braille, large print or audio, please call free of charge: 0800 198 5000 (UK only).
Please be ready to give the following information: Betacap, 00173/0149.
This is a service provided by the Royal National Institute of Blind People (RNIB).
Tatmore Place, Gosmore, Hitchin, Herts, SG4 7QR
+44 (0)1462 458 866
+44 (0)1462 420 565